Updates From Celgene in Follicular Lymphoma, Marginal Zone Lymphoma, Beta Thalassemia, and other Rare Diseases
Celgene Corporation has recently announced two exciting updates for the rare disease community! Update #1 The first big announcement from Celgene was that their supplemental New Drug Application (sNDA) for…